TCL Archive DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program July 3, 1981
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003